Skip to main content

Breast Cancer Clinical Trials

Review the breast cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 919

FES-PET/CT Scans for the Optimization of Tamoxifen Dose in Patients with Estrogen Receptor Positive, ESR1 Mutant Metastatic or Unresectable Breast Cancer
Status: Active
Location: 2 locations
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Status: Active
Location: 2 locations
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
Status: Active
Location: 2 locations
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
Status: Active
Location: 2 locations
Video Conference Delivered Cognitive-Behavioral Therapy for Chemotherapy-Related Cognitive Dysfunction in Patients with Stage I-III Breast Cancer
Status: Active
Location: 2 locations
Radiation Therapy for the Treatment of Patients with Metastatic Breast Cancer with Disease Progression at a Limited Number of Sites, BOSS Trial
Status: Active
Location: 2 locations
Paclitaxel before Surgery in Treating Patients with Breast Cancer
Status: Active
Location: 2 locations
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
Status: Active
Location: 2 locations
Radiofrequency Electromagnetic Fields Therapy using the TheraBionic P1 Device prior to Surgery for the Treatment of Stage I-III Resectable Breast Cancer
Status: Active
Location: 2 locations
Image Guided Radiation Therapy with MRI for the Treatment of Cancer, CONFIRM Study
Status: Active
Location: 2 locations
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
Status: Active
Location: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
Comparing Length of Treatment with Immunotherapy in Patients with Advanced Solid Tumors
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Local Consolidative Therapy to Extend the Efficacy of Systemic Therapy in Oligoprogressive Metastatic Cancer, EXTEND-OP Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients with Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Riluzole for the Improvement of Brain-Derived Neuropathic Factor Levels in Cancer Survivors Experiencing Cancer-Related Cognitive Impairment
Status: Active
Location: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
Abemaciclib Alone or in Combination with Hydroxychloroquine for the Treatment of Patients with Breast Cancer, ABBY Trial
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy before Surgery for the Treatment of Patients with Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Turkey Tail Mushroom for Treating Post-Menopausal Women with HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
Status: Active
Location: Mayo Clinic in Arizona, Scottsdale, Arizona
Capecitabine or Trastuzumab Emtansine with Radiation Therapy for the Treatment of High-Risk Stage I-IIIB Breast Cancer
Status: Active
Location: University of Virginia Cancer Center, Charlottesville, Virginia
Vitamin D Supplementation for the Improvement of Pathologic Complete Response in Vitamin D Deficient Patients Receiving Neoadjuvant Chemotherapy for Operable Triple Negative Breast Cancer
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Postoperative Circulating Tumor Deoxyribonucleic Acid (ctDNA) Surveillance to Guide the Treatment of Early-Stage Triple Negative Breast Cancer Patients with Residual Disease, PREDICT-RD Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Low or High Dose Radiation with Pembrolizumab and Preoperative Chemotherapy for the Treatment of Non-Metastatic Node Positive Triple Negative Breast Cancer, P-RAD(+)TN Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Pembrolizumab Plus Combination Chemotherapy before Surgery for the Treatment of Stage I Triple Negative Breast Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Trastuzumab, Pertuzumab and Docetaxel With or Without Carboplatin for the Treatment of Stage II-III HER2 Positive Breast Cancer, NeoTHERa Trial
Status: Active
Location: University of Kansas Cancer Center, Kansas City, Kansas